KO

KOMIPHARM INTERNATIONAL CO., LTD.

Biopharmaceutical company developing products for animal and human health.

041960 | KO

Overview

Corporate Details

ISIN(s):
KR7041960006
LEI:
Country:
South Korea
Address:
경기도 시흥시 경제로 17, 시흥시

Description

Komipharm International Co., Ltd. is a biopharmaceutical company engaged in the development, manufacturing, and sale of products for both animal and human health. Its Animal Health Division provides a portfolio of veterinary vaccines, pharmaceuticals, and disinfectants. The company's Pharmaceutical Division is dedicated to the research and development of novel therapeutic agents, with key research areas including anticancer drugs and treatments for cancer-related pain and autoimmune diseases. Leveraging extensive experience, the company focuses on intensive R&D to expand its presence in the global bio-industry.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-03-11 00:00
[기재정정]의결권대리행사권유참고서류
Korean 166.8 KB
2022-03-08 00:00
주주총회소집공고
Korean 174.5 KB
2022-03-08 00:00
의결권대리행사권유참고서류
Korean 145.9 KB
2022-02-24 00:00
주주총회소집결의
Korean 19.0 KB
2022-02-17 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.0 KB
2022-02-08 00:00
주식등의대량보유상황보고서(일반)
Korean 134.5 KB
2022-01-13 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean 15.9 KB
2022-01-03 00:00
전환가액의조정
Korean 10.4 KB
2021-12-23 00:00
[기재정정]타법인주식및출자증권취득결정
Korean 31.2 KB
2021-12-23 00:00
[기재정정]금전대여결정
Korean 23.2 KB
2021-12-22 00:00
단일판매ㆍ공급계약체결
Korean 10.7 KB
2021-12-21 00:00
타법인주식및출자증권취득결정
Korean 27.9 KB
2021-12-17 00:00
유상증자결정(종속회사의주요경영사항)
Korean 20.3 KB
2021-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2021-11-25 00:00
투자판단관련주요경영사항(COVID-19 감염 중등증 환자에게 PAX-1(경구용)을 경구투여하는 2개의 코호트 대한 파키스탄 식약처(DRAP) …
Korean 12.0 KB

Automate Your Workflow. Get a real-time feed of all KOMIPHARM INTERNATIONAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KOMIPHARM INTERNATIONAL CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KOMIPHARM INTERNATIONAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.